| Dr Sudha Pidikiti, MD, | |
|
700 Ne 87th Ave, Vancouver, WA 98664-1913 | |
| (360) 397-1500 | |
| (360) 253-3515 |
| Full Name | Dr Sudha Pidikiti |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 25 Years |
| Location | 700 Ne 87th Ave, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275623563 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pnrs Ft Vancouver | Vancouver, WA | Dialysis facility |
| Pnrs Clark County Dialysis Clinic | Battle ground, WA | Dialysis facility |
| Total Renal Care, Inc. | Battle ground, WA | Dialysis facility |
| Vancouver Dialysis Center | Vancouver, WA | Dialysis facility |
| Legacy Salmon Creek Medical Center | Vancouver, WA | Hospital |
| Peacehealth Southwest Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Vancouver Clinic Inc Ps | 3173436490 | 471 |
News Archive
Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery (JBJS).
Cutting Edge Information's most recent medical information study reveals that drug companies overwhelmingly agree that operating medical information call centers in-house is more efficient.
Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).
The U.S. Food and Drug Administration granted accelerated approval for brexucabtagene autoleucel (TECARTUS™, formerly KTE-X19) as the first and only CAR T-cell therapy for patients with mantle cell lymphoma (MCL) relapsed or refractory to prior treatments.
› Verified 9 days ago
| Entity Name | The Vancouver Clinic Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992759427 PECOS PAC ID: 3173436490 Enrollment ID: O20031111000793 |
News Archive
Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery (JBJS).
Cutting Edge Information's most recent medical information study reveals that drug companies overwhelmingly agree that operating medical information call centers in-house is more efficient.
Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).
The U.S. Food and Drug Administration granted accelerated approval for brexucabtagene autoleucel (TECARTUS™, formerly KTE-X19) as the first and only CAR T-cell therapy for patients with mantle cell lymphoma (MCL) relapsed or refractory to prior treatments.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sudha Pidikiti, MD, 700 Ne 87th Ave, Vancouver, WA 98664-1913 Ph: (360) 397-1500 | Dr Sudha Pidikiti, MD, 700 Ne 87th Ave, Vancouver, WA 98664-1913 Ph: (360) 397-1500 |
News Archive
Obesity is associated with longer hospital stays and higher costs in total knee replacement (TKR) patients, independent of whether or not the patient has an obesity-related disease or condition (comorbidity), according to a new study published in the Journal of Bone and Joint Surgery (JBJS).
Cutting Edge Information's most recent medical information study reveals that drug companies overwhelmingly agree that operating medical information call centers in-house is more efficient.
Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).
The U.S. Food and Drug Administration granted accelerated approval for brexucabtagene autoleucel (TECARTUS™, formerly KTE-X19) as the first and only CAR T-cell therapy for patients with mantle cell lymphoma (MCL) relapsed or refractory to prior treatments.
› Verified 9 days ago
Kanuboddu Nagarjuna Reddy, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave Ste 220, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. David Steiger, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 505 Ne 87th Ave Ste 301, Vancouver, WA 98664 Phone: 360-514-7374 Fax: 360-514-7384 | |
Phillip M Cullison Bonner, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1000 | |
Louise M Schultz, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-882-2778 | |
Marissa Krienke, MD Nephrology Medicare: Medicare Enrolled Practice Location: 700 Ne 87th Ave Ste And240, Vancouver, WA 98664 Phone: 360-882-2778 | |
Joel David Mclarry, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Suite 210, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. Samuel Everett George, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19005 Se 34th St Bldg 3, Vancouver, WA 98683 Phone: 360-726-6720 Fax: 360-726-6729 |